Injectable Drug Delivery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Injectable Drug Delivery Devices Market is segmented by Device Type (Conventional Drug Delivery Devices and Self-injectable Drug Delivery Devices), Therapeutic Application, and Geography.

Market Snapshot

 Injectable drug delivery devices market Overview
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 11.5 %
 Injectable drug delivery devices market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The injectable drug delivery devices market is expected to show rapid growth due to the growing burden of chronic diseases, benefits, and convenience, leading to increased demand for self injectors and growth of the biologics market, leading to increased demand for injectors.

The growing burden of chronic diseases has led to a rise in the overall use of syringes, particularly disposable syringes. It has been observed that most deaths by chronic diseases can be attributed to cardiovascular diseases, obesity, and diabetes. This is expected to affect the emerging countries the most, as population growth is found to be the most significant factor in developing areas.

A major number of drugs and therapies that address these chronic ailments are now found to be available. However, the use of syringes in the management of any chronic ailment is inevitable. Syringes can either be a part of sample collection during diagnosis or treatment regimen, like osteoarthritis. Consequently, the rise in the prevalence of chronic diseases is expected the drive the growth of the market studied.

Furthermore, technological advancements, improving patient compliance, beneficial reimbursement policies, and the rise of biologics in the pharmaceutical market are some of the other factors propelling the growth of the market.

Scope of the Report

As per the scope of the report, the injectable devices are being used to administer drugs either intravenously, through intramuscular or subcutaneously, and are considered as injectable drug delivery devices. The injectable method is the most frequently used method for drugs that have poor oral bioavailability, targeted drug delivery systems, and delivery of drugs at the site of action. Injectable drug delivery is used in conditions, such as hormonal imbalance, cystic fibrosis, autoimmune diseases, pain, Wilson’s disease, hemophilia, hepatitis C, and ribose-5-phosphate isomerase deficiency.

By Devices Type
Conventional Drug Delivery Devices
Advanced Drug Delivery Devices
Prefilled Syringes
Injectable Pens
Auto Injectors
Needle-free Injectors
Other Device Types
By Therapeutic Application
Cardiovascular Disease
Autoimmune Disorders
Other Therapeutic Applications
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East & Africa
South Africa
Rest of Middle-East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Self-injectable Drug Delivery Devices is Anticipated to be Dominant during the Forecast Period

There have been boundless innovations and developments in self-injectable devices which is driving the growth of the market. The other major advantages associated with self-injectable devices are that they are found to be of convenient usage and low healthcare cost. These self-injectables were developed with the help of patient feedback, to provide the most adaptable devices, which have high precision of drug delivery, and are easy to use.

In addition to this, with the innovations in self-injectable devices, the acceptance of these products has increased over the past few years. Nevertheless, the advantages of self-injectable injections and increasing awareness of self-administration have helped in driving the overall market studied, during the forecast period.

 Injectable drug delivery devices market Key Trends

The North America Region Dominates the Injectable Drug Delivery Devices Market

North America has been found dominating the injectable drug delivery devices, due to the increasing aging population and the rising number of chronic diseases that may influence the usage of injectables. According to the National Cancer Institute, 2018, there were an estimated 1,735,350 new cases of cancer that were being diagnosed in the United States. Therefore, chemotherapy drugs are being delivered to these cancer patients through injectable devices. Hence, increasing prevalence of chronic diseases and the adoption of new technologies related to injectables in the United States may help in propelling the growth of the overall market.

There are also some of the other factors that include; the large pool of patient population, increasing healthcare expenditure, rising focus of various companies, increasing healthcare awareness, and increase in government funding. Hence, all these factors are found associated with the growth of the market.

 Injectable drug delivery devices market Growth by Region

Competitive Landscape

The companies present in the market are found focusing on product innovations, expansions, finding new markets, or innovating their core competency to expand their individual market shares. There are also innovations taking place in injectable drug delivery systems that are the trend for the global injectable drug delivery market.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Burden of Chronic Diseases

      2. 4.2.2 Benefits and Convenience in Self Injectors

      3. 4.2.3 Growth of the Biologics Market Leading to Increased Demand for Injectors

    3. 4.3 Market Restraints

      1. 4.3.1 Injuries and Infections Caused by Needles

      2. 4.3.2 Increasing Use of Alternative Delivery Methods

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Devices Type

      1. 5.1.1 Conventional Drug Delivery Devices

      2. 5.1.2 Advanced Drug Delivery Devices

        1. Prefilled Syringes

        2. Injectable Pens

        3. Auto Injectors

        4. Needle-free Injectors

        5. Other Device Types

    2. 5.2 By Therapeutic Application

      1. 5.2.1 Cardiovascular Disease

      2. 5.2.2 Diabetes

      3. 5.2.3 Oncology

      4. 5.2.4 Autoimmune Disorders

      5. 5.2.5 Hepatitis

      6. 5.2.6 Other Therapeutic Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East & Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Baxter International Inc.

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Eli Lilly and Company

      4. 6.1.4 Gerresheimer AG

      5. 6.1.5 Novo Nordisk A/S

      6. 6.1.6 Pfizer Inc.

      7. 6.1.7 Schott AG

      8. 6.1.8 Terumo Corporation

      9. 6.1.9 Teva Pharmaceutical Industries Ltd

      10. 6.1.10 West Pharmaceutical Services Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Injectable Drug Delivery Devices Market market is studied from 2018 - 2026.

The Injectable Drug Delivery Devices Market is growing at a CAGR of 11.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Baxter International Inc., Becton, Dickinson and Company, Gerresheimer AG, Teva Pharmaceutical Industries Ltd, Eli Lilly and Company are the major companies operating in Injectable Drug Delivery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!